3st5: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:3st5.png|left|200px]] | [[Image:3st5.png|left|200px]] | ||
{{STRUCTURE_3st5| PDB=3st5 | SCENE= }} | {{STRUCTURE_3st5| PDB=3st5 | SCENE= }} | ||
===Crystal structure of wild-type HIV-1 protease with C3-Substituted Hexahydrocyclopentafuranyl Urethane as P2-Ligand, GRL-0489A=== | ===Crystal structure of wild-type HIV-1 protease with C3-Substituted Hexahydrocyclopentafuranyl Urethane as P2-Ligand, GRL-0489A=== | ||
{{ABSTRACT_PUBMED_21800876}} | {{ABSTRACT_PUBMED_21800876}} | ||
==About this Structure== | ==About this Structure== | ||
[[3st5]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3ST5 OCA]. | [[3st5]] is a 2 chain structure of [[Virus protease]] with sequence from [http://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3ST5 OCA]. | ||
==See Also== | |||
*[[Virus protease|Virus protease]] | |||
==Reference== | ==Reference== |
Revision as of 15:35, 26 July 2012
Crystal structure of wild-type HIV-1 protease with C3-Substituted Hexahydrocyclopentafuranyl Urethane as P2-Ligand, GRL-0489ACrystal structure of wild-type HIV-1 protease with C3-Substituted Hexahydrocyclopentafuranyl Urethane as P2-Ligand, GRL-0489A
Template:ABSTRACT PUBMED 21800876
About this StructureAbout this Structure
3st5 is a 2 chain structure of Virus protease with sequence from Human immunodeficiency virus 1. Full crystallographic information is available from OCA.
See AlsoSee Also
ReferenceReference
- ↑ Ghosh AK, Chapsal BD, Parham GL, Steffey M, Agniswamy J, Wang YF, Amano M, Weber IT, Mitsuya H. Design of HIV-1 Protease Inhibitors with C3-Substituted Hexahydrocyclopentafuranyl Urethanes as P2-Ligands: Synthesis, Biological Evaluation, and Protein-Ligand X-ray Crystal Structure. J Med Chem. 2011 Jul 29. PMID:21800876 doi:10.1021/jm200649p